Related Experiment Video
Updated: May 6, 2026
Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
Published on: September 11, 2012
Study the Impact of NADPH oxidase1,TNF-alpha and Cyclooxygenase-2 On Colon Cancer Patients
Ashwaq N Mowat1, Zainab N Al-Abady1
1Department of Chemistry, Faculty of Sciences, University of Al-Qadisiyah, Iraq.
Background:
Colon cancer is a major health concern globally, being one of the most commonly diagnosed cancers. Inflammation and oxidative stress are critical factors contributing to its development and progression. Understanding the roles of key molecules such as NOX1, TNF-α, and COX-2 in these processes may provide insights into potential biomarkers for early detection and targeted therapy.
Objective:
This study aims to investigate the roles of NADPH oxidase 1 (NOX1), Tumor Necrosis Factor-alpha (TNF-α), and Cyclooxygenase-2 (COX-2) in colon cancer progression and their possible implications in the disease context.
Methods:
A comparative analysis was conducted involving 40 colon cancer patients (15 males, 25 females; aged 20-78 years) and 40 healthy controls (17 males, 23 females; aged 21-75 years). Blood samples were collected from participants between October 10, 2023, and February 18, 2024. The levels of NOX1, TNF-α, and COX-2 were measured using the enzyme-linked immunosorbent assay (ELISA) method.
Results:
The study found significantly elevated levels of TNF-α in colon cancer patients (100.9-454.3 ng/L) compared to healthy controls (24.85-216.9 ng/L). Additionally, COX-2 levels were markedly higher in patients (239.4-690.53 units/L) than in controls (23.78-115.5 units/L). NOX1 levels were also elevated in cancer patients (4.0-14.92) relative to healthy subjects (0.89-9.39). These findings suggest an association between increased levels of TNF-α, COX-2, and NOX1 with a higher risk of colon cancer.
Conclusion:
The findings suggest that elevated levels of TNF-α, COX-2, and NOX1 may be associated with the progression of colon cancer, indicating their potential involvement in the disease. Specifically, higher levels of TNF-α and COX-2 could be linked to increased cancer cell proliferation and metastasis, while elevated NOX1 levels might be related to oxidative stress and cellular transformation in colon cancer patients.
Insights
Elevated levels of Tumor Necrosis Factor-alpha (TNF-α), Cyclooxygenase-2 (COX-2), and NADPH oxidase 1 (NOX1) are linked to colon cancer progression. These molecules may serve as potential biomarkers for early detection and targeted therapies in colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Colon cancer is a leading global health concern, with inflammation and oxidative stress playing key roles in its development.
- Understanding the involvement of molecules like NOX1, TNF-α, and COX-2 is crucial for identifying early detection biomarkers and targeted therapies.
Purpose of the Study:
- To investigate the roles of NADPH oxidase 1 (NOX1), Tumor Necrosis Factor-alpha (TNF-α), and Cyclooxygenase-2 (COX-2) in colon cancer progression.
- To explore the potential implications of these molecules as biomarkers in the context of colon cancer.
Main Methods:
- A comparative analysis was performed on 40 colon cancer patients and 40 healthy controls.
- Blood samples were analyzed for the levels of NOX1, TNF-α, and COX-2 using the enzyme-linked immunosorbent assay (ELISA) method.
Main Results:
- Significantly elevated levels of TNF-α, COX-2, and NOX1 were observed in colon cancer patients compared to healthy controls.
- Specific ranges for elevated levels were noted: TNF-α (100.9-454.3 ng/L), COX-2 (239.4-690.53 units/L), and NOX1 (4.0-14.92).
- These findings indicate a strong association between increased levels of these molecules and a higher risk of colon cancer.
Conclusions:
- Elevated TNF-α, COX-2, and NOX1 levels are potentially associated with colon cancer progression.
- Higher TNF-α and COX-2 may correlate with increased cancer cell proliferation and metastasis.
- Increased NOX1 levels might be linked to oxidative stress and cellular transformation in colon cancer.
